REGISTERED
on 24 May 2022
Last Applicant/ Owned by
675 West Kendall Street
Cambridge
MA
02142
Serial Number
87927601 filed on 18th May 2018
Registration Number
6739619 registered on 24th May 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ALNYLAM
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, heredita Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1, Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), porphyria, hereditary ATTR amyloidosis, hepatic porphyrias, primary hyperoxaluria type 1
First Use Date in General
31st Aug 2018
First Use Date in Commerce
31st Aug 2018
Mark Details
Serial Number
No 87927601
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 30th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 30th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 25th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th May 2022 | REGISTERED-PRINCIPAL REGISTER |
| 21st Apr 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 20th Apr 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th Apr 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 08th Apr 2022 | USE AMENDMENT FILED |
| 08th Apr 2022 | TEAS STATEMENT OF USE RECEIVED |